Construction and in vitro evaluation of pH-sensitive nanoparticles to reverse drug resistance of breast cancer stem cells

Pan L, Han J, Lin M. Targeting breast cancer stem cells directly to treat refractory breast cancer. Front Oncol. 2023;13: 981247.

Wu Y, Shum HCE, Wu K, Vadgama J. From interaction to intervention: how mesenchymal stem cells affect and target triple-negative breast cancer. Biomedicines. 2023;11(4): 1182.

Itoo AM, Paul M, Ghosh B, Biswas S. Oxaliplatin delivery via chitosan/vitamin E conjugate micelles for improved efficacy and MDR-reversal in breast cancer. Carbohydr Polym. 2022;282: 119108.

Krishnan N, Titus MA, Thapar R. The prolyl isomerase pin1 regulates mRNA levels of genes with short half-lives by targeting specific RNA binding proteins. PLoS ONE. 2014;9(1): e85427.

Wang JZ, Liu BG, Zhang Y. Pin1-based diagnostic and therapeutic strategies for breast cancer. Pharmacol Res. 2015;93:28–35.

Wulf GM, Ryo A, Wulf GG, Lee SW, Niu T, Petkova V, Lu KP. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 2001;20(13):3459–72.

Luo ML, Gong C, Chen CH, et al. Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer. Cancer Res. 2014;74(13):3603–16.

Wei S, Kozono S, Kats L, Nechama M, Li W, Guarnerio J, Luo M, You MH, Yao Y, Kondo A, Hu H, Bozkurt G, Moerke NJ, Cao S, Reschke M, Chen CH, Rego EM, Lo-Coco F, Cantley LC, Lee TH, Wu H, Zhang Y, Pandolfi PP, Zhou XZ, Lu KP. Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer. Nat Med. 2015;21(5):457–66.

Li W, Gong H, Fu Y, Sun J, Wang Y. Novel pH-sensitive nanoparticles based on prodrug strategy to delivery all-trans retinoic acid for breast cancer. Colloids Surf B Biointerfaces. 2022;219: 112838.

Liu H, Song Y, Qiu H, et al. Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis. Cell Death Differ. 2020;27(3):966–83.

Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008;8(10):755–68.

Pan Y, Ma X, Liu C, Xing J, Zhou S, Parshad B, Schwerdtle T, Li W, Wu A, Haag R. Retinoic acid-loaded dendritic polyglycerol-conjugated gold nanostars for targeted photothermal therapy in breast cancer stem cells. ACS Nano. 2021;15(9):15069–84.

Johnstone RW, Cretney E, Smyth MJ. P-glycoprotein protects leukemia cells against caspasedependent but not caspase-independent, cell death. Blood. 1999;93(3):1075–85.

Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta. 1976;455(1):152–62.

Fritz F, Howard EM, Hoffman MM, et al. Evidence for altered ion transport in Saccharomyces cerevisiae overexpressing human MDR 1 protein. Biochemistry. 1999;38(13):4214–26.

Zang X, Cheng M, Zhang X, Chen X. Quercetin nanoformulations: a promising strategy for tumor therapy. Food Funct. 2021;12(15):6664–81.

Li L, Wang T, Xu ZL, Yu Y, Chen W, Chen F. [Effects of schisandrin B on reversing multidrug resistance in human breast cancer cells transfected with mdr1 gene]. Zhonghua Yi Xue Za Zhi. 2005;85(23):1633–7.

Li X, Zhao Y, Gong S, Song T, Ge J, Li J, Zhang J, Fu K, Zheng Y, Ma L. Schisandrin B ameliorates acute liver injury by regulating EGFR-mediated activation of autophagy. Bioorg Chem. 2023;130: 106272.

Li W, Xu Q, Wang Y, Chen D. Poly(β-amino esters)-based barriers for tumor targeted delivery system. Acta Pharm Sin. 2015;50(4):434–9.

Li W, Zhang X, Nan Y, Jia L, Sun J, Zhang L, Wang Y. Hyaluronidase and pH dual-responsive nanoparticles for targeted breast cancer stem cells. Front Oncol. 2021;11: 760423.

Zhang H, Xue Q, Zhou Z, He N, Li S, Zhao C. Co-delivery of doxorubicin and hydroxychloroquine via chitosan/alginate nanoparticles for blocking autophagy and enhancing chemotherapy in breast cancer therapy. Front Pharmacol. 2023;14: 1176232.

Andreotti AM, Goiato MC, Moreno A, Nobrega AS, Pesqueira AA, dos Santos DM. Influence of nanoparticles on color stability, microhardness, and flexural strength of acrylic resins specific for ocular prosthesis. Int J Nanomed. 2014;9:5779–87.

Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17(1):20–37.

Zhao Q, Chen J, Zhang Z, Xiao C, Zeng H, Xu C, Yang X, Li Z. Modulating tumor mechanics with nanomedicine for cancer therapy. Biomater Sci. 2023. https://doi.org/10.1039/d3bm00363a.

Gao N, Fu Y, Gong H, Liu H, Li W. Hyaluronic acid and cholecalciferol conjugate based nanomicelles: synthesis, characterization, and cytotoxicity against MCF-7 breast cancer cells. Carbohydr Res. 2022;522: 108706.

Sang R, Fan R, Deng A, Gou J, Lin R, Zhao T, Hai Y, Song J, Liu Y, Qi B, Du G, Cheng M, Wei G. Degradation of hexokinase 2 blocks glycolysis and induces GSDME-Dependent pyroptosis to amplify immunogenic cell death for breast cancer therapy. J Med Chem. 2023. https://doi.org/10.1021/acs.jmedchem.3c00118.

Davatgaran-Taghipour Y, Masoomzadeh S, Farzaei MH, Bahramsoltani R, Karimi-Soureh Z, Rahimi R, Abdollahi M. Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective. Int J Nanomed. 2017;12:2689–702.

Fang F, Wang S, Song Y, Sun M, Chen WC, Zhao D, Zhang J. Continuous spatiotemporal therapy of a full-API nanodrug via multi-step tandem endogenous biosynthesis. Nat Commun. 2023;14(1):1660.

Li W, Sun J, Zhang X, Jia L, Qiao M, Zhao X, Hu H, Chen D, Wang Y. Synthesis and characterization of pH-responsive PEG-poly (β-amino ester) block copolymer micelles as drug carriers to eliminate cancer stem cells. Pharmaceutics. 2020;12(2): 111.

Li Z, Qiu L, Chen Q, Hao T, Qiao M, Zhao H, Zhang J, Hu H, Zhao X, Chen D, Mei L. pH-sensitive nanoparticles of poly(L-histidine)-poly(lactide-co-glycolide)-tocopheryl polyethylene glycol succinate for anti-tumor drug delivery. Acta Biomater. 2015;11:137–50.

Li WQ, Wu JY, Xiang DX, Luo SL, Hu XB, Tang TT, Sun TL, Liu XY. Micelles loaded with puerarin and modified with triphenylphosphonium cation possess mitochondrial targeting and demonstrate enhanced protective effect against isoprenaline-induced H9c2 cells apoptosis. Int J Nanomed. 2019;14:8345–60.

Chen Q, Shan T, Liang Y, Xu Y, Shi E, Wang Y, Li C, Wang Y, Cao M. A biomimetic phototherapeutic nanoagent based on bacterial double-layered membrane vesicles for comprehensive treatment of oral squamous cell carcinoma. J Mater Chem B. 2023. https://doi.org/10.1039/d3tb02046k.

Ma L, Ruan L, Liu H, Yang H, Feng Y. ABCB1 C3435T polymorphism is associated with leukemia susceptibility: evidence from a meta-analysis. Onco Targets Ther. 2015;8:1009–15.

Harazono Y, Kho DH, Balan V, et al. Extracellular galectin-3 programs multidrug resistance through Na+/K+-ATPase and P-glycoprotein signaling. Oncotarget. 2015;6(23):19592–604.

Krstić D, Krinulović K, Vasić V. Inhibition of Na+/K(+)-ATPase and mg(2+)-ATPase by metal ions and prevention and recovery of inhibited activities by chelators. J Enzyme Inhib Med Chem. 2005;20(5):469–76.

Loo TW, Clarke DM. Recent progress in understanding the mechanism of P-glycoproteinmediated drug efflux. J Membr Biol. 2005;206(3):173–85.

Chen M, Li W, Zhang X, Dong Y, Hua Y, Zhang H, Gao J, Zhao L, Li Y, Zheng A. In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes. Int J Nanomed. 2017;12:5487–500.

Fan M, Zhang J, Tsai CW, Orlando BJ, Rodriguez M, Xu Y, Liao M, Tsai MF, Feng L. Structure and mechanism of the mitochondrial Ca2 + uniporter holocomplex. Nature. 2020;582(7810):129–33.

Xu F, Li M, Qian Q, Chen L, Yang Y, Ji TF, Li JG. β-Acetoxyisovalerylalkannin suppresses proliferation and induces ROS-based mitochondria-mediated apoptosis in human melanoma cells. J Asian Nat Prod Res. 2023;13:1–15.

De Toni L, Cosci I, Sabovic I, Di Nisio A, Guidolin D, Pedrucci F, Finocchi F, Dall’Acqua S, Foresta C, Ferlin A, Garolla A. Membrane cholesterol inhibits progesterone-mediated sperm function through the possible involvement of ABHD2. Int J Mol Sci. 2023;24(11): 9254.

Wang Z, Cui J, Li D, Ran S, Huang J, Chen G. Morin exhibits a neuroprotective effect in MPTP-induced Parkinson’s disease model via TFEB/AMPK-mediated mitophagy. Phytomedicine. 2023;116: 154866.

Wang R, Yin C, Liu C, Sun Y, Xiao P, Li J, Yang S, Wu W, Jiang X. Phenylboronic acid modification augments the lysosome escape and antitumor efficacy of a cylindrical polymer brush-based prodrug. J Am Chem Soc. 2021;143(49):20927–38.

Wang C, Zhang J, Wei X, Yang M, Ma W, Yu R, Liu M, Jiang T. Design, synthesis, and biological evaluation of marine lissodendrins B analogues as modulators of ABCB1-mediated multidrug resistance. Mar Drugs. 2023;21(5): 314.

Mukerabigwi JF, Tang R, Cao Y, Mohammed F, Zhou Q, Zhou M, Ge Z. Mitochondria-targeting polyprodrugs to overcome the drug resistance of cancer cells by self-amplified oxidation-triggered drug release. Bioconjug Chem. 2023;34(2):377–91.

Li K, Cai X, Fan Y, Jin M, Xie Y, Jing Z, Zang X, Han Y. Codelivery of Que and BCL-2 siRNA with Lipid-Copolymer Hybrid Nanocomplexes for Efficient Tumor Regression. ACS Biomater Sci Eng. 2023;9(8):4805–4820.

Oh H, Jeong E, Lee JS, Kim J, Lee D, Kim BS, Sung D, Koo H, Choi WI, Tae G. ROS-responsive PEGylated ferrocene polymer nanoparticles with improved stability for tumor-selective chemotherapy and imaging. Mater Today Bio. 2023;22: 100774.